MM&M2d
PBMs vs. the world: ‘Invisible middlemen’ of healthcare industry face continued scrutiny
For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
CVS Health 2024 Profits Eclipse $4.6 Billion Despite Rising Costs
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...
Wisconsin man died after asthma inhaler cost skyrocketed to $539, lawsuit says
The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the Wisconsin man's death in 2024.
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic' practices
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Insulin prices are falling due to market forces — no price caps required
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
NBC Bay Area3d
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic' practices
CVS owns Caremark, one of the nation's three largest PBMs that collectively administer roughly 80% of prescriptions in the U.S. Those middlemen negotiate rebates with drug manufacturers on behalf ...